India's fertility services market size was valued at USD 1.1 Billion in 2022. The fertility services industry is projected to grow from USD 1.31 Billion in 2023 to USD 5.18 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 18.80% over the projected period (2023 - 2032).Growing technological advancements in fertility treatment, an increase in the adoption of unhealthy lifestyles, and an increase in the healthcare industry for infertility treatment are the main market drivers anticipated to propel India's fertility services market.
Source: MRFR Database, Primary Research, Secondary Research, and Analyst Review
India's fertility services market CAGR is expanding due to increased awareness of infertility treatments. Changing societal attitudes, rising education levels and enhanced healthcare awareness contribute to a growing willingness among couples to seek fertility services. Advances in reproductive technologies, coupled with improved accessibility to fertility clinics, further drive the market. Increased media coverage and education campaigns play a pivotal role in dispelling stigmas associated with infertility, encouraging more individuals and couples to explore fertility services, thus fostering the expansion of the fertility services market in India.
Moreover, the number of product launches and approvals for fertility services products and technological advancement in fertility services are expected to fuel the market growth. In addition, the rise in the adoption of in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) technology due to the high success rate in treating infertility and the rise in the adoption of fertility services by the population drives the fertility services market revenue during the forecast period. Numerous elements in either the male or female reproductive systems can lead to infertility. It is sometimes impossible to pinpoint the root causes of infertility. Infertility in females may result from tubal abnormalities, such as obstructed fallopian tubes, which are, in turn, brought on by untreated sexually transmitted diseases (STIs) or aftereffects of a botched abortion, postpartum sepsis, or abdominal/pelvic surgery. Additionally, uterine conditions that may be inflammatory (such as
The India fertility services market segmentation is based on infertility, including male infertility and female infertility. The male segment dominated the market mostly due to increased awareness of male reproductive health, advancements in diagnostic technologies for male infertility, and a growing acceptance of assisted reproductive techniques contribute to the market's focus on addressing and treating male infertility concerns in the country.
The India fertility services market segmentation, based on procedure, includes assisted reproductive technology (ART), in-vitro fertilization, artificial insemination, surrogacy, and others. In-vitro fertilization held a major market share owing to the increasing infertility rates, changing lifestyles, and greater awareness of assisted reproductive technologies. IVF's success rates, coupled with evolving societal perspectives, contribute to its prominence, making it a key driver in India's fertility services market growth.
The India fertility services market segmentation, based on services, includes donor and non-donor. The non-donor held a major market share owing to the rise in the prevalence of infertility, the increasing prevalence of infertility among the male population due to unhealthy lifestyles, and technological advancement in the development of different fertility services.
The India fertility services market segmentation, based on end-user, includes fertility clinics, hospitals, clinical research institutes, and surgical centers. The fertility clinics held a major market share due to increasing infertility rates, changing lifestyles, delayed pregnancies, and a growing acceptance of fertility treatments. Fertility clinics play a crucial role in addressing the diverse reproductive needs of individuals and couples, contributing to market growth.
Figure 1: India Fertility Services Market, by End-User, 2022 & 2032 (USD Billion)
Source: Primary Research, MRFR Database, Secondary Research, and Analyst Review
The fertility services market is witnessing growth driven by a rise in the prevalence of infertility and a rise in the number of product launches and product approvals for fertility services products. In addition, an increase in the adoption of key strategies such as collaboration, acquisition, agreement, business expansion, and partnership by market players who manufacture fertility services products is anticipated to boost the growth of the fertility services market. Moreover, an increase in the adoption of unhealthy lifestyles by the male and female population, such as consumption of alcohol, smoking, and lack of physical activity, is anticipated to drive the prevalence of infertility. Technological improvements in the healthcare sector and the high presence of market players who manufacture fertility services products are anticipated to fuel market growth during the forecast period.
Fertility Services Key Market Participants & Competitive Insights
Prominent market players invest heavily in R&D to enhance their product lines, expanding the fertility services market even more. Market players are also undertaking different strategic activities to expand their footprint, with substantial market developments such as new product establishment, mergers and acquisitions, contractual agreements, and collaboration with other organizations. The fertility services industry must deliver cost-effective items to extend and stay in a more competitive and rising market climate.
Major players in the fertility services market are attempting to extend market needs by investing in research and development operations, including Olympus Corporation, The Cooper Companies Inc., Instituto Bernabeu, Virtus Health, CooperSurgical, Inc., Vitrolife, CARE Fertility, INVO Bioscience, Monash IVF, Fertility Focus Limited, Carolinas Fertility Institute, Apollo Hospitals Enterprise Ltd., Merck KGaA, LABOTECT GMBH, and Medicover.
Key Companies in the Fertility Services market include
Fertility Services Industry Developments
October 2020: Nova IVF Fertility, India's major IVF chain, has introduced a new state-of-the-art IVF center in Patna. With an inheritance spanning 10 yrs in the field of helped reproductive therapy & over 35000 IVF pregnancies, Nova IVF brings in the most cutting-edge fertility treatment to Eastern India.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 1.1 Billion |
| Market Size 2023 | USD 1.31 Billion |
| Market Size 2032 | USD 1.18 Billion |
| Compound Annual Growth Rate (CAGR) | 17.50% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Growth Factors, Revenue Forecast, Market Competitive Landscape, and Trends |
| Segments Covered | Infertility, Procedure, Services, End-User and Region |
| Countries Covered | India |
| Key Companies Profiled | Olympus Corporation, The Cooper Companies Inc., Instituto Bernabeu, Virtus Health, CooperSurgical, Inc., Vitrolife, CARE Fertility, INVO Bioscience, Monash IVF, Fertility Focus Limited, Carolinas Fertility Institute, Apollo Hospitals Enterprise Ltd., Merck KGaA, LABOTECT GMBH, and Medicover |
| Key Market Opportunities | Rising continuous decline in fertility rates |
| Key Market Dynamics | Increase in the healthcare industry for infertility treatment |
Frequently Asked Questions (FAQ) :
The India fertility services market size was esteemed at USD 1.1 Billion in 2022.
The market is anticipated to expand at a CAGR of 17.50% during the forecast period, 2023-2032.
The prominent players in the market are Olympus Corporation, The Cooper Companies Inc., Instituto Bernabeu, Virtus Health, CooperSurgical, Inc., Vitrolife, CARE Fertility, INVO Bioscience, Monash IVF, Fertility Focus Limited, Carolinas Fertility Institute, Apollo Hospitals Enterprise Ltd., Merck KGaA, LABOTECT GMBH, and Medicover.
The male category dominated the market in 2022.
The in-vitro fertilization category had the largest share of the market.
The non-donor category dominated the market in 2022.
The fertility clinics category had the largest share of the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
ยฉ 2024 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)
